Kerecis ehf Pipeline Insight and Competitive Landscape, 2023
Powered by ![]()
Unlock hidden opportunities in the Medical Devices industry
Empower your strategies with our Kerecis ehf Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions.
Kerecis ehf (Kerecis) operates as a medical device company that provides products that treat chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic, and oral wounds, for dura mater repair, breast reconstruction, and abdominal wall reconstruction, and for surgical stapling. It also develops mOmega3 fatty acid (fish-sourced fatty acids) technology for use in several dermatological indications such as psoriasis, eczema, dermatitis, keratosis pilaris, and pseudofolliculitis. Kerecis also provides fish-skin acellular dermal matrix products including Omega3 Wound, Omega3 Dura, Omega3 Hernia, Omega3 Pectus, Omega3 Seal, and topical creams including Smooth with mOmega3, Footguard with mOmega3, Psoria with mOmega3 and Xma with mOmega3. The company uses complete acellular fish skin for tissue regeneration by transplantation. Kerecis is headquartered in Isafjordur, Iceland.
GlobalData’s Medical Devices company profile report, “Kerecis ehf Pipeline Insight and Competitive Landscape, 2023″ provides information about the company overview and analysis on their pipeline products.
This company profile report provides key information and data related to:
- Top level information about the company performance and their pipeline products
- Review details of major pipeline products which include developmental activities including pipeline territories, and estimated approval dates
This company profile report enables you to:
- Access significant analysis and insights to improve R&D strategies
- Formulate market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
- 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
- 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
- 79,000+ medical equipment company profiles
- 5,600+ company profiles of medical equipment manufacturers in China and India
- 2,200+ company profiles of medical equipment manufacturers in Japan
- 1,200+ companies’ revenue splits and market shares
- 1,600+ quarterly and annual medical equipment company financials
- 850+ medical equipment company SWOTs
- 38,000+ pipeline product profiles
- 91,600+ marketed product profiles
- 65,600+ clinical trials
- 41,500+ trial investigators
- 7,000+ reports on companies with products in development
- 44,000+ deals in the medical equipment industry
- 1,100+ surgical and diagnostic procedures by therapy area
- 50+ key healthcare indicators by country
- 431,000+ Themes Content Items
- 600+ Influencers
- 2000+ Analysts & Researchers
- 0.6m+ Community Members
- 1,41,000+ Macroeconomic Indicators
- 1,013,000+ City Indicators
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Scope
- Market share
- Product portfolio
- Subsidiaries
- Revenue
- Pipeline products overview
- Sector analysis
- Approval timeline for pipeline products
- Pipeline products by geography
- Pipeline products by various stages of development
Reasons to Buy
- Strategic Positioning: Gain insights into Kerecis ehf’s market share, revenue and subsidiaries.
- Strategic Alignment: Analyse the diverse product portfolio to align your strategies with industry trends.
- Strategic Navigation: Navigate the medical devices sector with in-depth sector analysis along with pipeline products and their approval timeline and geographical distribution.
Key Players
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Medical Devices reports